Kevin Fettes, PhD

Principal and Founder at FTS Pharma Consulting, LLC

Speaker

Kevin has been working in the oligonucleotides field since starting his Ph.D. at the University of London in 1995. Subsequently he worked for Avecia Biotechnology, now Nitto Denko Avecia for 8 years across both their original Scottish site in Grangemouth and then Milford, Massachusetts, USA. Since 2009 he has held positions as Head of CMC at RXi Pharmaceuticals, Galena Biopharma and Dicerna Pharmaceuticals. In 2016 Kevin founded FTS Pharma Consulting, LLC to primarily assist early-phase oligonucleotide clients with their Technical, Regulatory CMC and Quality Assurance challenges.